Skip to main content

Your search for “Cancer Immunotherapy” returned 113 results

SDSC’s Comet Supercomputer Helps Benchmark Cancer Immunotherapy Tool

March 24, 2020

Rice University researchers used the Comet supercomputer at SDSC to evaluate their new molecular docking too to help improve cancer immunotherapy outcomes by identifying more effective personalized treatments.

How a Plant Virus Could Protect and Save Your Lungs From Metastatic Cancer

September 14, 2021

Using a virus that grows in black-eyed pea plants, researchers developed a new therapy that could keep metastatic cancers from spreading to the lungs, as well as treat established tumors in the lungs.

SPARK Gala Returns April 25 to Support Cancer Research and Care

April 22, 2015

San Diego community members, physicians and cancer survivors will come together Saturday, April 25 at the Grand Del Mar for SPARK Gala, an evening to “ignite the fight against cancer.”

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

Exploding Shells Boost Immune Response to Brain Cancer

September 17, 2019

Researchers at the University of California San Diego figured out a way to combine FDA-approved ultrasound with engineered glass particles to boost the effectiveness of immunotherapy in glioblastomas.

How Ovarian Cancer Defies Immunotherapy

April 11, 2022

Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.

Researchers Say to Conquer Cancer You Need to Stop It Before It Becomes Cancer

September 16, 2016

…this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe…

Leukemia in Remission for First Patient to Undergo CAR T-Cell Immunotherapy in San Diego

August 4, 2016

…in San Diego to receive a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health.

UC San Diego Health and Eisenhower Health Affiliation Expands Cancer Services in Coachella Valley

January 11, 2018

…affiliation agreement to expand cancer services for residents of Coachella Valley. Starting in January 2018, as a member of the UC San Diego Health Cancer Network, patients of Eisenhower Health will have enhanced access to world-class cancer care, both at Eisenhower Lucy Curci Cancer Center and at UC San Diego…

At Initial Cancer Diagnosis, a Deeply Personalized Assessment

October 13, 2021

UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies have failed.

Category navigation with Social links